The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors (Q37410764)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 August 2009
edit
Language Label Description Also known as
English
The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors
scientific article published on 24 August 2009

    Statements

    The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors (English)
    Mark Watson
    Anne Roulston
    Laurent Bélec
    Xavier Billot
    Richard Marcellus
    Dominique Bédard
    Cynthia Bernier
    Stéphane Branchaud
    Helen Chan
    Kenza Dairi
    Karine Gilbert
    Daniel Goulet
    Michel-Olivier Gratton
    Henady Isakau
    Anne Jang
    Abdelkrim Khadir
    Elizabeth Koch
    Manon Lavoie
    Michael Lawless
    Mai Nguyen
    Denis Paquette
    Emilie Turcotte
    Alvin Berger
    Gordon C Shore
    Pierre Beauparlant
    24 August 2009
    5872-5888

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit